FA
ORCL icon

Fagan Associates’s Oracle ORCL Stock Holding History

Fagan Associates’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Sell
24,518
-515
-2% -$83.7K 0.5% 51
2025
Q4 		$4.88M Buy
25,033
+51
+0.2% +$12.1K 0.65% 43
2025
Q3 		$7.03M Buy
24,982
+350
+1% +$89.1K 0.97% 33
2025
Q2 		$5.39M Buy
24,632
+581
+2% +$93.8K 0.83% 38
2025
Q1 		$3.36M Buy
24,051
+6,025
+33% +$981K 0.56% 52
2024
Q4 		$3M Sell
18,026
-31
-0.2% -$5.51K 0.48% 60
2024
Q3 		$3.08M Buy
18,057
+1,140
+7% +$165K 0.52% 59
2024
Q2 		$2.39M Buy
16,917
+5,231
+45% +$650K 0.42% 61
2024
Q1 		$1.47M Buy
11,686
+3,220
+38% +$369K 0.28% 71
2023
Q4 		$893K Buy
8,466
+3,568
+73% +$389K 0.19% 68
2023
Q3 		$519K Buy
+4,898
New +$567K 0.13% 79
2018
Q2 		– Sell
-33,211
Closed -$1.52K – 114
2018
Q1 		$1.52K Buy
33,211
+841
+3% +$41.8K 0.65% 48
2017
Q4 		$1.53K Buy
32,370
+3,820
+13% +$187K 0.62% 47
2017
Q3 		$1.38M Buy
+28,550
New +$1.42M 0.68% 48

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fagan Associates's ORCL Position: Q1 2026 in Review

Fagan Associates reduced its Oracle (ORCL) stake by 2.1% in Q1 2026, selling an estimated $83.7K and leaving 24,518 shares worth $3.61M. The position accounts for 0.5% of the portfolio, ranked #51.

Fagan Associates first reported a position in ORCL in Q3 2017 and has held it in 14 quarters since. The position peaked at $7.03M in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Fagan Associates held 24,518 shares of Oracle worth $3.61M as of Q1 2026.
  • Fagan Associates sold 515 Oracle shares in Q1 2026, an estimated $83.7K.
  • Oracle made up 0.5% of Fagan Associates's portfolio in Q1 2026, its #51 holding.
  • Fagan Associates first reported a position in Oracle in Q3 2017 and has held it in 14 quarters since.
  • Fagan Associates's Oracle position peaked at $7.03M in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Fagan Associates's 13F filing for Q1 2026, filed 4 May 2026.